Synthesis and evaluation of O-propargyl containing propargylamine derivatives as multipotent ligands for the treatment of Alzheimer’s disease
Authors:
- Vinay KumarVKVinay Kumar
- Kailash JangidKJKailash Jangid
- Bharti DeviBDBharti Devi
- Jayapriya MishraJMJayapriya Mishra
- Naveen KumarNKNaveen Kumar
- Jasvinder Singh BhattiJBJasvinder Singh Bhatti
- Rakesh KumarRKRakesh Kumar
- Vinod KumarVKVinod Kumar
- 4 February 2026
- journal article
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1360
Abstract
No abstract availableFunding Information
- Washington Internships for Students of Engineering
- Council for Scientific and Industrial Research, South Africa
- Defence Science and Technology Group (DST/WISE-PhD/CS/2023/64)
- Defence Science and Technology Group (SR/FST/CS-I/2020/154)
- University Grants Commission (45/29/2022-/BIO/BMS)
This publication has 43 references indexed in Scilit:
- In vitro and in vivo Investigations of 4-Substituted 2-Phenylquinazoline derivatives as multipotent ligands for the treatment of Alzheimer’s diseaseBioorganic Chemistry, 2025
- Discovery of Small‐Molecules as Potential GSK‐3β Inhibitors for the Treatment of Alzheimer's Disease Using Pharmacophore‐Based Virtual ScreeningChemistrySelect, 2024
- Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease ModificationDrugs, 2023
- An update on the discovery and development of reversible covalent inhibitorsMedicinal Chemistry Research, 2023
- Impact of Alzheimer's association support and engagement in the AD/ADRD research community through the COVID‐19 pandemic and beyondAlzheimer's & Dementia, 2023
- Novel AP2238-clorgiline hybrids as multi-target agents for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluationBioorganic Chemistry, 2022
- Oxidative stress: The core pathogenesis and mechanism of Alzheimer’s diseaseAgeing Research Reviews, 2022
- Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitorsBioorganic Chemistry, 2018
- Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer’s disease therapyBioorganic & Medicinal Chemistry, 2014
- Acetylcholinesterase: structure and use as a model for specific cation—protein interactionsCurrent Opinion in Structural Biology, 1992